Cargando…

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study

BACKGROUND: Hallucinations are prevalent in schizophrenia and related psychotic disorders and may have severe consequences for the affected patients. Antipsychotic drug trials that specifically address the anti-hallucinatory effectiveness of the respective drugs in representative samples are rare. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnsen, Erik, Sinkeviciute, Igne, Løberg, Else-Marie, Kroken, Rune A, Hugdahl, Kenneth, Jørgensen, Hugo A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850701/ https://www.ncbi.nlm.nih.gov/pubmed/24079855 http://dx.doi.org/10.1186/1471-244X-13-241

Ejemplares similares

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial
por: Kjelby, Eirik, et al.
Publicado: (2011)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial
por: Sinkeviciute, Igne, et al.
Publicado: (2021)

White Matter Microstructural Differences between Hallucinating and Non-Hallucinating Schizophrenia Spectrum Patients
por: Beresniewicz, Justyna, et al.
Publicado: (2021)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

Dynamic Functional Connectivity Patterns in Schizophrenia and the Relationship With Hallucinations
por: Weber, Sarah, et al.
Publicado: (2020)

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)
por: Kjelby, Eirik, et al.
Publicado: (2023)

F184. TESTING THE GABA-GLUTAMATE HYPOTHESIS FOR SCHIZOPHRENIA IN RELATION TO AUDITORY HALLUCINATIONS - PRELIMINARY RESULTS
por: Hjelmervik, Helene, et al.
Publicado: (2018)

Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect
por: Sinkeviciute, Igne, et al.
Publicado: (2012)

Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia
por: Hjelmervik, Helene, et al.
Publicado: (2020)

T134. THE ROLE OF THE DEFAULT MODE NETWORK IN SCHIZOPHRENIA AND AUDITORY VERBAL HALLUCINATIONS – AN INVESTIGATION OF DYNAMIC FMRI RESTING STATE CONNECTIVITY
por: Weber, Sarah, et al.
Publicado: (2020)

M146. NEUROCHEMICAL MODULATION OF AUDITORY CORTEX FUNCTIONAL CONNECTIVITY IN PATIENTS WITH AUDITORY VERBAL HALLUCINATIONS
por: Weber, Sarah, et al.
Publicado: (2020)

A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
por: Nagaraj, Anil Kumar M., et al.
Publicado: (2009)

Glutamate- and GABA-Modulated Connectivity in Auditory Hallucinations—A Combined Resting State fMRI and MR Spectroscopy Study
por: Weber, Sarah, et al.
Publicado: (2021)

The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement
por: Anda, Liss, et al.
Publicado: (2016)

A Critical Review of Pro-Cognitive Drug Targets in Psychosis: Convergence on Myelination and Inflammation
por: Kroken, Rune A., et al.
Publicado: (2014)

Negative valence of hallucinatory voices as predictor of cortical glutamatergic metabolite levels in schizophrenia patients
por: Hjelmervik, Helene, et al.
Publicado: (2021)

The role of the primary auditory cortex in the neural mechanism of auditory verbal hallucinations
por: Kompus, Kristiina, et al.
Publicado: (2013)

The Beliefs about Voices Questionnaire – Revised: A factor structure from 450 participants
por: Strauss, Clara, et al.
Publicado: (2018)

S57. TREATMENT SATISFACTION IN ACUTE PHASE PSYCHOSIS: COMPARISON BETWEEN ANTIPSYCHOTIC NAïVE AND PREVIOUSLY MEDICATED PATIENTS
por: Stabell, Lena, et al.
Publicado: (2018)

Influence of different second generation antipsychotics on the QTc interval: A pragmatic study
por: Olsen, Roy E, et al.
Publicado: (2016)

Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
por: Chaudhry, Haroon Rashid, et al.
Publicado: (2008)

Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT
por: Anda, Liss, et al.
Publicado: (2021)

Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study
por: Hoekstra, Sanne, et al.
Publicado: (2021)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
por: Gabriel, A
Publicado: (2013)

Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine
por: Gianfrancesco, Frank, et al.
Publicado: (2005)

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
por: Johnsen, Erik, et al.
Publicado: (2016)

S87. THE INITIAL CHANGE IN THE SERUM LEVEL OF C-REACTIVE PROTEIN IN ACUTE PSYCHOSIS IS ASSOCIATED WITH COGNITIVE PERFORMANCE IN LATER PHASES
por: Fathian, Farivar, et al.
Publicado: (2018)

Corrigendum: An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2013)

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2012)

Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
por: Fathian, Farivar, et al.
Publicado: (2018)

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability
por: Løberg, Else-Marie, et al.
Publicado: (2014)

Left Temporal Lobe Structural and Functional Abnormality Underlying Auditory Hallucinations in Schizophrenia
por: Hugdahl, Kenneth, et al.
Publicado: (2009)

Patients with Schizophrenia Fail to Up-Regulate Task-Positive and Down-Regulate Task-Negative Brain Networks: An fMRI Study Using an ICA Analysis Approach
por: Nygård, Merethe, et al.
Publicado: (2012)

Corrigendum: Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: an fMRI study using an ICA analysis approach
por: Nygård, Merethe, et al.
Publicado: (2013)

Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole
por: Remmerie, Bart, et al.
Publicado: (2016)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
por: Aquino, Adriano, et al.
Publicado: (2018)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_38k4cb9pmranc3ro313dtc544a